Skip to main content
Fig. 2 | Cell & Bioscience

Fig. 2

From: Predictive biomarkers for the responsiveness of recurrent glioblastomas to activated killer cell immunotherapy

Fig. 2

Identification of predictive markers and their expression patterns. A Schematic workflow explaining the three steps needed to identify the TNFSF18, TNFSF4, and IL12RB2 genes. B Heatmap of 64 genes based on an AUC > 0.85, an overall survival p-value < 0.05, and a progression-free survival p-value < 0.05. C A barplot of probability of response to AKC therapy in a random forest model. According to the black line of probability = 0.5, responders and non-responders were clearly separated. D The mRNA expression levels of TNFRSF18, TNFSF4, and IL12RB2 in responders and non-responders are shown as boxplots

Back to article page